| INTRODUC TI ON
Gastric cancer (GC) is the fourth common gastrointestinal malignancy and the third leading cause of cancer-related death worldwide. 1 In addition, the existing bad phenomenon in Western and China is that many GC patients did not get accurate prognosis in the early stage of the disease, and a large proportion of patients are diagnosed only in the advanced stage. Despite recent developments in therapy, the prognosis of advanced gastric cancer patients remains poor. 2 Therefore, understanding the underlying molecular pathogenesis of GC progression and the development of novel therapeutic targets are extremely important.
Noninvasive blood-based biomarkers may provide some information on GC status. 3 However, current serum tumor biomarkers including carcinoembryonic antigen (CEA), carbohydrate antigen 19-9 (CA19-9), and CA72-4 have a low positive rate in GC diagnosis. 4 Thus, it is necessary to find novel noninvasive biomarkers for diagnosing and monitoring patients with GC.
Circular RNA (circRNA) is a newly discovered class of relatively stable noncoding RNAs formed by back-splicing events with tissue and cell-type specificity. 5, 6 Recently, several circRNAs have been detected in the blood and were used as biomarkers for cancer diagnosis due to their high stability, high abundance, and tissue specificity. 9, 10 Furthermore, an increasing number of studies have shown that circRNAs play important roles in various cancer-related processes, including proliferation, migration, invasion, and apoptosis. 14, 15 However, the roles of circRNAs in GC are largely unknown.
Ska3 is a member of the spindle and kinetochore-associated (Ska) protein complex, which is required for accurate chromosome segregation during mitosis. 18 Ska3 at chromosome 13q was recently identified as a gene involved in promoting malignant transformation in colorectal adenoma. 19 Hsa_circ_0000467 was a circRNA which can be searched in circBase (http://www.circbase.org). Moreover, hsa_circ_0000467 were encoded by the Ska3 gene and located at chr13:21742126-21742538. However, there is no high-throughput sequencing data or databases revealed hsa_circ_0000467 expression level in gastric cancer and the roles of hsa_circ_0000467 in gastric cancer remain to be elucidated.
To the best of our knowledge, this is the first study to investigate the hsa_circ_0000467 expression in gastric cancer tissues, plasmas, and cell lines. We also analyzed the relationship between hsa_ circ_0000467 expression and diagnosis and prognosis in patients.
Finally, the biological functions of hsa_circ_0000467 were explored in vitro. Our study demonstrated that hsa_circ_0000467 may serve as a new kind of biomarker for GC diagnosis and prognosis and may play a role in proliferation, invasion, migration, and apoptosis of GC.
| MATERIAL AND ME THODS

| Cell culture and transfection
Human GC cell lines, namely, HGC-27, MGC-803, AGS, NUGC-3, and GES-1, were obtained from the Cell Line Bank, Chinese Academy of Sciences. The cell lines were confirmed by PCR, and the cultures were free from mycoplasma contamination. 
| Clinical specimens
A total of 51 pairs of gastric cancer tissue samples and adjacent non- 
| Cellular fractionation
The nuclear and cytoplasmic fractions were extracted using NE-PER Nuclear and Cytoplasmic Extraction Reagents (Thermo Scientific, Waltham, MA, USA). Total RNA from the nuclear and cytoplasmic fractions was isolated using TRIzol (Life Technologies, Carlsbad, CA, USA).
| RNA isolation and real-time quantitative polymerase chain reaction
RNA isolation was performed using the TRIzol reagent according to the manufacturer's manual. Reverse transcription was performed with the ReverTra Ace qPCR RT kit (Toyobo, Osaka, Japan) using (forward) and 5′-GTTGTGGACTACGTGGAGACT-3′ (reverse);
GAPDH: 5′-GGTCGGAGTCAACGGATTTG-3′ (forward) and 5′-
ATGAGCCCCAGCCTTCTCCAT-3′ (reverse). All experiments were
performed three times independently. For the invasion assay, the transwell system and Matrigel BD Biosciences (New York, NY, USA) were used according to the manufacturer's protocol. 1 × 10 5 cells were seeded into the upper chambers precoated with Matrigel and cultured in serum-free medium.
| Cell proliferation, migration, and invasion assay
The lower compartment was filled with medium supplemented with 10% FBS as a chemoattractant. After incubation for 48 hours, the cells remaining in the upper chamber were removed, and the cells at the bottom of the insert were fixed, stained with 0.5% crystal violet, and counted under a microscope (Olympus Corp., Tokyo, Japan).
The results from three independent experiments were averaged. For the migration assay, the cells were seeded into the upper chambers without Matrigel coating. The rest of the assay was conducted as described for the invasion assay.
| Cell apoptosis assays
For apoptosis analysis, cells were labeled with Annexin V-FITC and PI (BD Biosciences, Franklin Lakes, NJ, USA) according to the manufacturer's protocol. Cell apoptosis was assessed using FACS Calibur flow cytometry (BD Biosciences).
| Statistical analysis
The median expression was regarded as the cutoff value for hsa_ circ_0000467 high and low expression, as previous described. 
| RE SULTS
| Hsa_circ_0000467 is upregulated in GC tissues and cell lines
Hsa_circ_0000467 is located on chr13:21742126-21742538 and is derived from the exon 4 of its host gene ( Figure 1A ). To assay the expression level of hsa_circ_0000467 in gastric cancer, we performed real-time PCR to detect its expression in tumor samples and gastric cancer cell lines. We designed a set of specific divergent primers to examine hsa_circ_0000467 expression and performed
Sanger sequencing of the amplified PCR product ( Figure 1B) . We found that hsa_circ_0000467 is upregulated in gastric cancer tissue samples vs corresponding adjacent tissue samples (n = 51, P < 0.05, Figure 1C ). Moreover, hsa_circ_0000467 levels in plasma samples of patients with gastric cancer were higher than those in healthy controls (n = 20, P < 0.05, Figure 1D ). Five cell lines including HGC-27, MGC-803, AGS, NUGC-3, and GES-1 were used in this study. In this study, GES-1 is the control normal cell line, as previous study described. 14 Figure 1E showed that hsa_circ_0000467 expression was upregulated in HGC-27, MGC-803, AGS, and NUGC-3, compared with GES-1 cells. These results suggest that hsa_circ_0000467 may act as an oncogene.
Currently, the miRNA "sponge" is the most well-known regulatory mechanism for circRNA effects. Thus, we predicted the circRNA-miRNA-mRNA network using Arraystar's homemade miRNA target prediction software and TargetScan and miRanda ( Figure 1F ). Figure 1G shows that predicted mRNAs may participate in numerous pathways; hence, further work is needed to uncover the mechanisms of hsa_circ_0000467 in GC progression.
To further investigate the role of hsa_circ_0000467 in gastric cancer, we fractionated the cells into nuclear and cytoplasmic fractions to detect the cellular localization of hsa_circ_0000467. We discovered that hsa_circ_0000467 was predominantly cytoplasmic in HGC-27
and AGS cells ( Figure 1H ). This result implies that endogenous hsa_ circ_0000467 can work as a miRNA sponge to repress miRNA function.
| Potential diagnostic values of hsa_ circ_0000467 in gastric cancer
To identify whether hsa_circ_0000467 can serve as a biomarker in gas- To validate the diagnostic value of hsa_circ_0000467, we assayed the plasma levels of hsa_circ_0000467 at preoperative and postoperative stage in another 20 gastric cancer patients. The plasma levels of hsa_circ_0000467 in postoperative patients were significantly decreased compared to preoperative patients (P < 0.05; Figure 2B ).
F I G U R E 1
Hsa_circ_0000467 is up-regulated in gastric cancer. A, hsa_circ_0000467 is circulated by exons; B, the Sanger sequencing of hsa_circ_0000467; C, the expression of hsa_circ_0000467 in gastric cancer tissue and corresponding adjacent tissues; D, the expression of hsa_circ_0000467 in plasma samples; E, the expression of hsa_circ_0000467 in cell lines; F, cytoscape was used to visualize hsa_ circ_0000467 -miRNA-mRNA; G, mRNA predicted participate in many pathways. H, Hsa_circ_0000467 was predominantly cytoplasmic. *P < 0.05, ***P < 0.001
| Upregulated hsa_circ_0000467 expression predicts aggressive clinicopathological characteristics and poor prognosis in GC patients after R0 gastrectomy
The data demonstrated that hsa_circ_0000467 expression was significantly upregulated in gastric cancer tissue and plasma samples of patients with gastric cancer. Therefore, we analyzed the association between hsa_circ_0000467 expression and clinicopathological characteristics and long-term outcomes in GC patients after gastrectomy. As shown in Table 1 , 32 of 51 (62.7%) patients had high hsa_circ_0000467 expression. We divided the patients into two groups according to the median hsa_circ_0000467 expression. A strong association was observed between hsa_ circ_0000467 expression and T classification, lymphatic invasion, and TNM stage (all P < 0.001; Table 1 ). The median follow-up of this study was 32 months; we found that patients with lower hsa_circ_0000467 expression have better prognoses than patients with higher expression ( Figure 3A) . Cox multivariate regression analysis showed that hsa_circ_0000467 is a novel independent prognostic factor ( Table 2 ). The prognostic efficiency of the combined hsa_circ_0000467 TNM stage (n = 51, AUC =0.779, 95% CI =0.650-0.908) was higher when compared to that using TNM stage (n = 51, AUC =0.708, 95% CI =0.562-0.853) alone ( Figure 3B ).
F I G U R E 2
Diagnostic value of hsa_circ_0000467 for GC patients. A, ROC curve of hsa_circ_0000467. B, The plasma levels of hsa_ circ_0000467 in preoperative and postoperative gastric cancer patients. *P < 0.05 
| Hsa_circ_0000467 induced GC proliferation, invasion, migration, and inhibited apoptosis in vitro
We transfected HGC-27 and AGS cells with shRNA1# (64736-1) and shRNA2# (64735-1; Figure 4A ). Thus, we selected shRNA2# for further study. CCK-8 assay was performed to investigate the effect of hsa_circ_0000467 on GC cell proliferation. We observed that hsa_circ_0000467 silencing inhibits proliferation of the HGC-27
and AGS cells compared to the control groups ( Figure 4B ). Then, we performed the transwell assay using the HGC-27 and AGS cells and found that hsa_circ_0000467 silencing inhibits invasion ( Figure 4C) and migration ( Figure 4D ) of the cells. Thus, these data suggest that hsa_circ_0000467 plays a tumor-promoting role.
We also investigated the role of hsa_circ_0000467 in apoptosis in GC cells. HGC-27 and AGS cells were transfected with hsa_ circ_0000467-silencing plasmid or scrambled nonspecific shRNA control. Knockdown of hsa_circ_0000467 in the cells increased the fraction of apoptotic cells ( Figure 4E ).
| D ISCUSS I ON
Numerous studies have shown that circRNAs exhibit aberrant expression in many types of cancer, including NSCLC, hepatocellular carcinoma, colorectal cancer, breast cancer, and esophageal squamous cell carcinoma. In this study, we used RT-qPCR assays to verify that hsa_circ_0000467 was upregulated in GC tissue vs adjacent tissue. The function of hsa_circ_000467 in tumor development and progression has not been investigated previously.
A number of circRNAs have been identified as ideal biomarkers
for cancer diagnosis, due to their highly conserved and remarkably stable. 7, 11, 21, 22 However, their clinical diagnostic value in gastric cancer remains largely unknown. In this study, we found that hsa_circ_0000467 was upregulated in gastric cancer tissues, cell lines, and plasmas of patients with gastric cancer. Importantly, we are the first to determine the potential diagnostic value of hsa_ circ_0000467. CEA, CA 19-9, and CA 72-4 are widely used in screening and auxiliary diagnosis of gastrointestinal malignancies. Chen et al reported that hsa_circ_0000190 is superior to commonly used serum cancer markers such as CEA and CA19-9 in gastric cancer.
23
Nonetheless, they had a low positive rate in early gastric cancer screening. 24 The sensitivity and specificity of CA19-9 were 0.605 and 0.559, respectively; the values for CEA were 0.686 and 0.593, respectively. 25 In this study, the sensitivity and specificity of CEA were 0.614 and 0.568, and for CA72-4, the sensitivity and specificity were 0.667 and 0.592, respectively. However, the sensitivity and specificity of plasma hsa_circ_0000467 were 0.705 and 0.648
indicating that hsa_circ_0000467 has higher sensitivity and specificity in the screening of gastric cancer. Apart from this, plasma hsa_circ_0000467 had a higher AUC value (0.790) than CEA (0.560) and CA72-4 (0.670). Our data indicate that hsa_circ_0000467 may be used as a potential noninvasive marker for the diagnosis of gastric cancer and is superior to commonly used gastric cancer biomarkers such as CEA and CA72-4; we thus suggest that a combination of plasma hsa_circ_0000467, CEA, and CA72-4 may increase the success rate of diagnostic procedures.
In subsequent studies, we have found that the plasma levels of hsa_circ_0000467 in postoperative patients are significantly decreased compared to those in preoperative patients (P < 0.01). This might be due mainly to a decrease in the release of tumor-derived nucleic acids after tumor excision. 26, 27 Thus, the peripheral blood levels of hsa_circ_0000467 in preoperative and postoperative patients are significantly changed. In summary, hsa_circ_0000467 may 
Hsa_circ_0000467 induce GC malignant biological behavior. A, HGC-27 and AGS cells were transfected with shRNA, including circRNAi (64736-1; shRNA1#) and circRNAi (64735-1; shRNA2#) and control plasmid; B, the effect of hsa_circ_0000467 on GCC proliferation; C, hsa_circ_0000467 induced cell invasion; D, hsa_circ_0000467 induced cell migration; E, apoptosis measured by flow cytometry. *P < 0.05, **P < 0.01, ***P < 0.001 circRNAs that has been proposed to inhibit tumor suppressor miR-7. Widespread expression of ciRS-7 in neuroblastomas, astrocytoma, renal cell, lung, and colorectal carcinomas implicates the role of ciRS-7 as a critical regulator in cancer. 31 However, the functions of circRNAs in GC are emerging only recently. In our study, we identified a novel circRNA hsa_circ_0000467 as a tumor promoter. We found that higher expression of hsa_circ_0000467
correlates with multiple clinicopathological factors such as larger tumor size, advanced T-stage, and lymph node metastasis; hence, patients with high hsa_circ_0000467 expression had a worse prognosis than those with low expression; this finding prompted us to investigate the function of hsa_circ_0000467. Using CCK8
and transwell assays, we demonstrated that knockdown of hsa_ circ_0000467 significantly inhibits proliferation, migration, and invasion of GC cells. These data indicate that hsa_circ_0000467 might participate in the occurrence and development of GC and might be a potential biomarker for prognosis and a therapeutic target for GC treatment.
Our results showed that hsa_circ_0000467 affects GC cell proliferation, apoptosis, and metastasis. However, the mechanisms of circRNA function in carcinogenesis and cancer progression have not been clearly elucidated. circRNAs may regulate the expression of oncogenic or tumor suppressor genes via different targets depending on the different types of cancer or even different stages of the disease. In most cases, circRNAs act as an miRNA sponge and form a circRNA-miRNA-mRNA axis.
22,32,33
There are some limitations to this study. First, the sample size was relatively small and the follow-up was relatively short; thus, these data have to be confirmed in a larger population with longer follow-up. Second, only one circRNA was investigated in this study.
Third, we performed only loss-of-function biological experiments.
Therefore, gain-of-function assays should be performed in the GC cells, and animal experiments are needed.
In conclusion, our study provides a novel potential circular RNA target in GC patients. To the best of our knowledge, this is the first study to investigate the expression, function, and diagnostic value of hsa_circ_0000467 in GC. Studies of the functions of hsa_ circ_0000467 can improve our understanding of the mechanisms underlying gastric cancer occurrence and progression, and our findings may offer a potential therapeutic target for treating this fatal disease. However, further research in an external validation setting is warranted.
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